HC-7366

Clinical trials for HC-7366 explained in plain language.

Never miss a new study

Get alerted when new HC-7366 trials appear

Sign up with your email to follow new studies for HC-7366, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for kidney cancer: experimental combo targets tumors

Disease control Recruiting now

This early-phase study tests whether adding an experimental drug (HC-7366) to standard immunotherapy (nivolumab, with or without ipilimumab) can help control advanced clear cell kidney cancer. About 35 adults with stage IV disease will participate. The main goal is to check safet…

Matched conditions: HC-7366

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 11, 2026 20:46 UTC

HC-7366

Get alerted when new HC-7366 trials appear

New hope for kidney cancer: experimental combo targets tumors